Retrospective Longitudinal Analysis: Loss to Follow Up Undergoing Antiretroviral Therapy in Kerti Praja Foundation Bali 2002-2012
DOI:
https://doi.org/10.53638/phpma.2014.v2.i1.p15Keywords:
loss to follow up, antiretroviral therapy, Kerti Praja Foundation BaliAbstract
Background and purpose: Lower loss to follow up (LTFU) is one indicator of the success of antiretroviral therapy (ART). In 2013 the Indonesian Ministry of Health reported that the cumulative percentage of LTFU was as high as 17.3%. To date, there has been no retrospective research into LTFU on people living with HIV/AIDS (PLHIV) in Bali, particularly to investigate PLHIV client characteristics.
Methods: This descriptive longitudinal study was conducted to analyze secondary data from records of PLHIV initiating ART between 2002-2012 at Clinic Amertha, Kerti Praja Foundation (YKP). The sample was PLHIV receiving ART at the YKP from 2002-2012 that had first received ART in YKP and had minimum 2 consultations.
Data used was that recorded in the medical records. Variables were: age, gender, occupation, the presence of ART supervisor, and HIV transmission mode. Data were analyzed descriptively to obtain insight into characteristics of LTFU clients per 100 person years (PY). Length of time since LTFU was assessed.
Results: The sample was 548: 77 (14,1%) were LTFU with crude incidence of LTFU at 5.15 per 100 PY. Median time of LTFU was not reached in this study, because of the low outcome incidence. Specific LTFU incidence was higher in women (6.6 per 100 PY), younger age (6.0 per 100 PY), and female sex workers (7.3 per 100 PY). Lack of ART supervisor (9.3 per 100 PY) and homosexual (9.1 per 100 PY) also had higher LTFU incidence.
Conclusion: Specific LTFU incidence was higher in women, younger age, female sex workers, lack of ART supervisor, and homosexual.
References
Depkes RI. Situasi HIV/AIDS di Indonesia Tahun 1987 2006. Jakarta : Depkes RI; 2006.
Depkes. Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral pada Orang Dewasa. Jakarta : Depkes RI; 2011.
Martin W.G.B., D.François, M. Landon, R.B. David, B. Andrew N. Denis, S. Mauro, L. Christian, K. Olivia, M. Margaret, S. Eduardo, E. Matthias, A. Xavier. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income. Bull World Health Organ. [Internet]. 2008; vol.86 n.7 Genebra Jul. 2008. Available from : http://www.ncbi.nlm.gov/pubmed
Kemenkes RI. Laporan Perkembangan HIV-AIDS Triwulan IV Tahun 2013. Jakarta : Kemenkes RI; 2014.
Odafe S, Idoko O, Badru T, Aiyenigba B, Suzuki C, Khamofu H, et al. Patients’ demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals. J. Int. AIDS Soc. [Internet]. 2012 Jan [cited 2013 Oct 7];15(2):17424. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3494164&tool=pmcentrez&rendertype=abstract.
Zhou J, Tanuma J, Chaiwarith R, Lee CKC, Law MG, Kumarasamy N, et al. Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD. AIDS Res. Treat. [Internet]. 2012 Jan [cited 2013 Oct 7];2012:375217. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3296146&tool=pmcentrez&rendertype=abstract.
Gerver, S.M.,T.R. Chadborn, F. Ibrahim, B. Vasta, V.C. Delpech, P.J. Easterbrook. High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort. Journal of the International AIDS Society. [Internet]. 2010; 13, p.29. Available from: http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=2924265&tool=pmcentrez&rendertype=abstract .
Saka B, Landoh DE, Patassi A, D’Almeida S, Singo A, Gessner BD, et al. Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients. Pan Afr. Med. J. [Internet]. 2013 Jan [cited 2013 Oct 2];15:35. Available from: http://www.pubmed central.nih.gov/articlerender.fcgi?artid=3758855&tool=pmcentrez&rendertype=abstract.
Sahay S, Reddy KS, Dhayarkar S. Optimizing adherence to antiretroviral therapy. Indian J. Med. Res. [Internet]. 2011 Dec [cited 2014 Jun 12];134(6):835–49. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=3284093&tool=pmcentrez&rendertype=abstract.
Huet C, Ouedraogo A, Konaté I, Traore I, Rouet F, Kaboré A, et al. Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. BMC Public Health [Internet]. 2011 Jan [cited 2014 Jun 11];11:700. Available from: http://www.pubmed central.nih.gov/articlerender.fcgi?artid=3191514&tool=pmcentrez&rendertype=abstract.
Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, Alcaraz I, et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med. [Internet]. 2006 Apr [cited 2013 Oct 16];7(3):140–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1649462.
Maru DS-R, Khakha DC, Tahir M, Basu S, Sharma SK. Poor follow-up rates at a self-pay northern Indian tertiary AIDS clinic. Int. J. Equity Health [Internet]. 2007 Jan [cited 2013 Oct 7];6:14. Available from: http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=2200646&tool=pmcentrez&rendertype=abstract.
Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, et al. Loss to follow-up in an international, multicentre observational study. HIV Med. [Internet]. 2008 May [cited 2013 Oct 1];9(5):261–9. Available from: http://www.ncbi. nlm.nih.gov/pubmed/18400074.
Hønge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open [Internet]. 2013 Jan [cited 2013 Nov 7];3(10):e003499. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=3808780&tool=pmcentrez&rendertype=abstract.
Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS [Internet]. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA; 2009 Mar 20 [cited 2014 Mar 16];23(3):203–10. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2776987&tool=pmcentrez&rendertype=abstract.
Krishnan S, Wu K, Smurzynski M, Bosch RJ, Benson CA, Collier AC, et al. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis. HIV Clin. Trials [Internet]. [cited 2013 Oct 7];12(4):190–200. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=3207266&tool=pmcentrez&rendertype=abstract.
Mimiaga MJ, Safren SA, Dvoryak S, Reisner SL, Needle R, Woody G. “We fear the police, and the police fear us”: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care [Internet]. Routledge; 2010 Nov [cited 2014 Apr30];22(11):1305–13. Available from: http:// dx.doi.org/10.1080/09540121003758515.
USAID. Interventions to Improve Adherence to Antiretroviral Therapy: A Review of the Evidence. Arlington: USAID; 2006.
Graham SM, Mugo P, Gichuru E, Thiong’o A, Macharia M, Okuku HS, et al. Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high-risk sexual behavior, including men who have sex with men, in coastal Kenya. AIDS Behav. [Internet]. 2013 May [cited 2014 Jun 11];17(4):1255–65. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3633780&tool=pmcentrez&rendertype=abstract
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Desak Nyoman Widyanthini, Anak Agung Sawitri Sawitri, Dewa Nyoman Wirawan
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
**Creative Commons Attribution 4.0 International License (CC BY 4.0)**
*Welcome to the world of open collaboration and shared creativity! The Creative Commons Attribution 4.0 International License (CC BY 4.0) empowers creators to share their work with the world while maintaining certain rights.*
**Key Points:**
1. **Freedom to Share:** CC BY 4.0 allows creators to share their work globally, granting others the freedom to use, remix, and build upon it.
2. **Attribution Requirement:** Users can use the work for any purpose, even commercially, as long as they provide appropriate credit to the original creator.
3. **Flexibility:** Applicable to various content types—text, images, music, videos—the license fosters a diverse range of creations.
**Common Use Cases:**
- **Education:** Widely used for educational materials, promoting open learning environments.
- **Research:** Applied to scholarly articles, accelerating the dissemination of knowledge.
**How to Use:**
1. **Share:** Share your work with the world, marking it with the CC BY 4.0 license.
2. **Attribution:** Users, when utilizing the work, must provide proper attribution to honor the original creator.
**Conclusion:**
CC BY 4.0 contributes to a more open and collaborative digital landscape. Join the movement of shared knowledge and creativity!
*For full license details, visit [Creative Commons](https://creativecommons.org/licenses/by/4.0/).*
